BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3781236)

  • 1. Complex segregation analysis of low levels of plasma high-density lipoprotein cholesterol in a sample of nuclear families in Jerusalem.
    Friedlander Y; Kark JD; Stein Y
    Genet Epidemiol; 1986; 3(5):285-97. PubMed ID: 3781236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic study of hypoalphalipoproteinemia.
    Byard PJ; Borecki IB; Glueck CJ; Laskarzewski PM; Third JL; Rao DC
    Genet Epidemiol; 1984; 1(1):43-51. PubMed ID: 6544231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in multifactorial inheritance of plasma lipids and lipoproteins in ethnically diverse families in Jerusalem.
    Friedlander Y; Kark JD; Stein Y
    Genet Epidemiol; 1986; 3(2):95-112. PubMed ID: 3710141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segregation analysis of HDL cholesterol in the NHLBI Family Heart Study and in Utah pedigrees.
    Kronenberg F; Coon H; Ellison RC; Borecki I; Arnett DK; Province MA; Eckfeldt JH; Hopkins PN; Hunt SC
    Eur J Hum Genet; 2002 Jun; 10(6):367-74. PubMed ID: 12080388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach to the multivariate analysis of high-density-lipoprotein cholesterol in a large kindred: the Bogalusa Heart Study.
    Amos CI; Wilson AF; Rosenbaum PA; Srinivasan SR; Webber LS; Elston RC; Berenson GS
    Genet Epidemiol; 1986; 3(4):255-67. PubMed ID: 3744022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No common major gene for apolipoprotein A-I and HDL3-C levels: evidence from bivariate segregation analysis.
    Juo SH; Beaty TH; Duffy DL; Coresh J; Kwiterovich PO
    Genet Epidemiol; 1999; 16(1):54-68. PubMed ID: 9915567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calculation of LDL-cholesterol from total cholesterol, triglyceride and HDL-cholesterol: a comparison of methods in the Jerusalem Lipid Research Clinic Prevalence Study.
    Friedlander Y; Kark JD; Eisenberg S; Stein Y
    Isr J Med Sci; 1982 Dec; 18(12):1242-52. PubMed ID: 7161056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial aggregation of total cholesterol, triglyceride and high-density lipoprotein-cholesterol in an Israeli population sample.
    Friedlander Y; Cohen T; Stenhouse N; Davies AM; Stein Y
    Isr J Med Sci; 1982 Nov; 18(11):1137-43. PubMed ID: 7161046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex segregation analysis of plasma lipid and lipoprotein variables in a Jerusalem sample of nuclear families.
    Friedlander Y; Kark JD
    Hum Hered; 1987; 37(1):7-19. PubMed ID: 3557465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A re-examination of major locus hypotheses for high density lipoprotein cholesterol level using 2,170 persons screened in 55 Utah pedigrees.
    Hasstedt SJ; Ash KO; Williams RR
    Am J Med Genet; 1986 May; 24(1):57-67. PubMed ID: 3706413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
    Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias.
    Pirro M; Siepi D; Lupattelli G; Roscini AR; Schillaci G; Gemelli F; Vaudo G; Marchesi S; Pasqualini L; Mannarino E
    Metabolism; 2003 Apr; 52(4):432-6. PubMed ID: 12701054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipids and lipoproteins in adult Jews of different origins: the Jerusalem Lipid Research Clinic prevalence study.
    Halfon ST; Rifkind BM; Harlap S; Kaufmann NA; Baras M; Slater PE; Halperin G; Eisenberg S; Davies AM; Stein Y
    Isr J Med Sci; 1982 Nov; 18(11):1113-20. PubMed ID: 7161043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.
    Moriyama Y; Okamura T; Inazu A; Doi M; Iso H; Mouri Y; Ishikawa Y; Suzuki H; Iida M; Koizumi J; Mabuchi H; Komachi Y
    Prev Med; 1998; 27(5 Pt 1):659-67. PubMed ID: 9808796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans.
    Arya R; Duggirala R; Almasy L; Rainwater DL; Mahaney MC; Cole S; Dyer TD; Williams K; Leach RJ; Hixson JE; MacCluer JW; O'Connell P; Stern MP; Blangero J
    Nat Genet; 2002 Jan; 30(1):102-5. PubMed ID: 11743583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
    Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.